Sign in Register

Drug class

Meningococcal Vaccines - Serogroup B

Meningococcal Vaccines - Serogroup B comprise an immunologic class of recombinant protein-based vaccines designed for active immunization against *Neisseria meningitidis* serogroup B. Read more about Meningococcal Vaccines - Serogroup B

8 drugs in this class 3 manufacturers

Related classes & indications

Japanese Encephalitis VaccineVaccines · 2 prescription drugs Hepatitis B VaccineVaccines · 24 prescription drugs Meningococcal VaccinationTop indication · 30 prescription drugs

Showing 1–8 of 8 drugs

Sort

BEXSERO (meningococcal group B vaccine, 4-component)

MENINGOCOCCAL VACCINES - SEROGROUP B · MENINGOCOCCAL VACCINATION

GSK

TRUMENBA (Neisseria meningitidis group B, lipidated fHBP recombinant)

MENINGOCOCCAL VACCINES - SEROGROUP B · MENINGOCOCCAL VACCINATION

Wyeth Pharmaceutical

PENBRAYA (PF) (meningococ A,C,Y,W-135,TT comp/N. mening B,fHBP rec comp/PF)

MENINGOCOCCAL VACCINES - SEROGROUPS A,C,Y,W135 · MENINGOCOCCAL VACCINATION

Laboratories Div

PENBRAYA MENB COMPONENT (PF) (Neisseria meningitidis B (A05 & B01), (fHBP), rec component)

MENINGOCOCCAL VACCINES - SEROGROUP B · MENINGOCOCCAL VACCINATION

Laboratories Div

PENBRAYA (meningococ A,C,Y,W-135,TT comp/N. mening B,fHBP rec comp/PF)

MENINGOCOCCAL VACCINES - SEROGROUPS A,C,Y,W135 · MENINGOCOCCAL VACCINATION

Laboratories Div

PENBRAYA MENB COMPONENT (Neisseria meningitidis B (A05 & B01), (fHBP), rec component)

MENINGOCOCCAL VACCINES - SEROGROUP B · MENINGOCOCCAL VACCINATION

Laboratories Div

PENMENVY MEN A-B-C-W-Y (meningoc A,C,Y,W-135,DT cmp/N.mening B NHBA,NadA,fHBP,OMV/PF)

MENINGOCOCCAL VACCINES - SEROGROUPS A,C,Y,W135 · MENINGOCOCCAL VACCINATION

GSK

PENMENVY MENB COMPONENT (Neisseria meningitidis group B (NHBA, NadA, fHBP, OMV) comp)

MENINGOCOCCAL VACCINES - SEROGROUP B · MENINGOCOCCAL VACCINATION

GSK

Filter & compare in the drug finder → Opens the drug finder with Meningococcal Vaccines - Serogroup B preselected. Add indication or manufacturer filters there.

About Meningococcal Vaccines - Serogroup B.

Meningococcal Vaccines - Serogroup B comprise an immunologic class of recombinant protein-based vaccines designed for active immunization against *Neisseria meningitidis* serogroup B.

Because the serogroup B capsular polysaccharide mimics human neural tissue and is poorly immunogenic, these vaccines instead present surface-exposed bacterial proteins—such as factor H binding protein, neisserial adhesin A, neisseria heparin-binding antigen, and outer membrane vesicles—to stimulate serum bactericidal antibodies that mediate complement-dependent bacterial lysis.

Clinically, this class is utilized to prevent life-threatening invasive meningococcal disease, primarily acute bacterial meningitis and meningococcemia, in adolescents, young adults, and individuals at heightened risk due to anatomical or functional asplenia, persistent complement component deficiencies, or outbreak exposure.

fda.gov
Meningococcal Vaccines - Serogroup B comprise an immunologic class of recombinant protein-based vaccines designed for active immunization against *Neisseria meningitidis* serogroup B
fda.gov
Meningococcal Vaccines - Serogroup B comprise an immunologic class of recombinant protein-based vaccines designed for active immunization against *Neisseria meningitidis* serogroup B
justtheinserts.com
Meningococcal Vaccines - Serogroup B comprise an immunologic class of recombinant protein-based vaccines designed for active immunization against *Neisseria meningitidis* serogroup B. Because the serogroup B capsular polysaccharide mimics human neural tissue and is poorly immunogenic, these vaccines instead present surface-exposed bacterial proteins—such as factor H binding protein, neisserial adhesin A, neisseria heparin-binding antigen, and outer membrane vesicles—to stimulate serum bactericid...
who.int
Meningococcal Vaccines - Serogroup B comprise an immunologic class of recombinant protein-based vaccines designed for active immunization against *Neisseria meningitidis* serogroup B. Because the serogroup B capsular polysaccharide mimics human neural tissue and is poorly immunogenic, these vaccines instead present surface-exposed bacterial proteins—such as factor H binding protein, neisserial adhesin A, neisseria heparin-binding antigen, and outer membrane vesicles—to stimulate serum bactericid...
meningvax.com
Meningococcal Vaccines - Serogroup B comprise an immunologic class of recombinant protein-based vaccines designed for active immunization against *Neisseria meningitidis* serogroup B. Because the serogroup B capsular polysaccharide mimics human neural tissue and is poorly immunogenic, these vaccines instead present surface-exposed bacterial proteins—such as factor H binding protein, neisserial adhesin A, neisseria heparin-binding antigen, and outer membrane vesicles—to stimulate serum bactericid...
fda.gov
Clinically, this class is utilized to prevent life-threatening invasive meningococcal disease, primarily acute bacterial meningitis and meningococcemia, in adolescents, young adults, and individuals at heightened risk due to anatomical or functional asplenia, persistent complement component deficiencies, or outbreak exposure
cdc.gov
Clinically, this class is utilized to prevent life-threatening invasive meningococcal disease, primarily acute bacterial meningitis and meningococcemia, in adolescents, young adults, and individuals at heightened risk due to anatomical or functional asplenia, persistent complement component deficiencies, or outbreak exposure